搜索临床试验以:PPI 取消处方计划
总计56个结果
-
VA Office of Research and DevelopmentVHA Pharmacy Benefits Management Services VA Center For Medication Safety完全的
-
Nantes University Hospital完全的
-
Basque Health Service未知促进健康 | 健康行为 | 健康教育 | 患者教育 | 辅导 | 行为疗法西班牙
-
Duke University完全的
-
University of ValenciaGeneralitat Valenciana招聘中乳腺癌女性 | 自主神经功能障碍 | 老年心血管疾病 | 心脏代谢综合征 | 代谢紊乱,脂质西班牙
-
McGill UniversityWorld Bank; Institute of Socio-Economic Research on Development and Democracy (ISERDD); ACCESS...完全的
-
University Clinical Research Center, MaliColumbia University; Fogarty International Center of the National Institute of Health完全的
-
University of ChileHarvard Medical School (HMS and HSDM); Boston Children's Hospital; Wellesley College未知
-
Nantes University Hospital完全的
-
Johns Hopkins UniversityThe Rita and Alex Hillman Foundation; Abell Foundation; Richman Foundation; Sherman Family Foundation 和其他合作者招聘中
-
Steno Diabetes Center CopenhagenDepartment of Medicine, Endocrine Unit Herlev University Hospital, Herlev, Denmark主动,不招人
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)招聘中
-
Shenyang Northern Hospital尚未招聘
-
Women and Infants Hospital of Rhode IslandNational Institute of Mental Health (NIMH)完全的
-
Kantonsspital Winterthur KSWKrebsforschung Schweiz, Bern, Switzerland; Sponser Sport Food AG; Leitwert GmbH; SNAQ AG; Kantonsspital...招聘中
-
Alberto Pilotto尚未招聘
-
University of California, IrvineEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National...完全的
-
University of ZurichWaid City Hospital, Zurich完全的
-
SecuraBio终止CD20+ 滤泡性淋巴瘤比利时, 意大利, 美国, 西班牙, 英国, 法国
-
Dana-Farber Cancer InstituteSecura Bio, Inc.主动,不招人
-
Brian JonasNational Cancer Institute (NCI); Pharmacyclics LLC.招聘中
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)撤销
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人复发性套细胞淋巴瘤 | 套细胞淋巴瘤 | CCND1 阳性 | CCND2阳性 | CCND3阳性 | CD20阳性 | 难治性套细胞淋巴瘤美国
-
National Institute of Allergy and Infectious Diseases...Clinical Trials in Organ Transplantation终止
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
National Cancer Institute (NCI)Celgene Corporation主动,不招人Ann Arbor III 期 1 级滤泡性淋巴瘤 | Ann Arbor III 期 2 级滤泡性淋巴瘤 | Ann Arbor IV 期 1 级滤泡性淋巴瘤 | Ann Arbor IV 期 2 级滤泡性淋巴瘤 | Ann Arbor II 期 3 级连续性滤泡性淋巴瘤 | Ann Arbor II 期 3 级非连续性滤泡性淋巴瘤 | Ann Arbor III 期 3 级滤泡性淋巴瘤 | Ann Arbor IV 期 3 级滤泡性淋巴瘤 | Ann Arbor II 期 1 级连续性滤泡性淋巴瘤 | Ann Arbor II 期 1 级非连续性滤泡性淋巴瘤 | Ann Arbor II 期 2 级连续性滤泡性淋巴瘤 | Ann Arbor...美国
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science University尚未招聘
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人复发性套细胞淋巴瘤 | 复发性弥漫性大 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 | 难治性套细胞淋巴瘤 | 转化为弥漫性大 B 细胞淋巴瘤的滤泡性淋巴瘤美国
-
National Cancer Institute (NCI)招聘中Ann Arbor II 期弥漫性大 B 细胞淋巴瘤 | Ann Arbor III 期弥漫性大 B 细胞淋巴瘤 | Ann Arbor IV 期弥漫性大 B 细胞淋巴瘤 | 艾滋病相关淋巴瘤美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人母细胞期慢性粒细胞白血病,BCR-ABL1 阳性 | 费城染色体阳性 | 复发性急性淋巴细胞白血病 | 复发性慢性粒细胞白血病,BCR-ABL1 阳性 | 难治性急性淋巴细胞白血病 | 难治性慢性粒细胞白血病,BCR-ABL1 阳性 | t(9;22)美国
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)主动,不招人
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人间变性大细胞淋巴瘤,ALK 阳性 | 成人 T 细胞白血病/淋巴瘤 | 血管免疫母细胞性T细胞淋巴瘤 | 肝脾T细胞淋巴瘤 | 成熟 T 细胞和 NK 细胞非霍奇金淋巴瘤 | 肠病相关的T细胞淋巴瘤 | 未特指的外周 T 细胞淋巴瘤 | 间变性大细胞淋巴瘤,ALK 阴性 | Ann Arbor II 期非皮肤间变性大细胞淋巴瘤 | Ann Arbor III 期非皮肤间变性大细胞淋巴瘤 | Ann Arbor IV 期非皮肤间变性大细胞淋巴瘤美国, 加拿大
-
Yazeed Sawalha招聘中弥漫性大 B 细胞淋巴瘤 | 转化为弥漫性大 B 细胞淋巴瘤的滤泡性淋巴瘤 | 转化为弥漫性大 B 细胞淋巴瘤的边缘区淋巴瘤美国
-
M.D. Anderson Cancer Center招聘中
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人